Pfizer, Mylan Beat EpiPen Antitrust Suit, For Now
By Lauren Berg · July 26, 2021, 7:36 PM EDT
A Kansas federal judge on Monday tossed a lawsuit alleging Mylan Pharmaceuticals and Pfizer Inc. inflated the price of emergency allergy medication EpiPen, saying the pharmacy operator behind the suit doesn't...
To view the full article, register now.